In vitro metabolism of acetylcholinesterase inhibitors containing 3-[F-18]f
luoromethylbenzyl-([F-18]1) and 4-[F-18]fluorobenzyl-piperidine moieties ([
F-18]2) was studied and compared with the in vivo metabolism. Defluorinatio
n of the [F-18]1 mainly occurred to generate [F-18]fluoride ion both in vit
ro and in vivo, In contrast, the [F-18]2 was converted into an unknown pola
r metabolite in both metabolism methods and another metabolite, 4-[F-18]flu
orobenzoic acid in vitro. These results demonstrated that the in vitro meth
od can be used to predict the in vivo metabolism of both radiotracers. (C)
2001 Elsevier Science Inc. All rights reserved.